0001809300-20-000001.txt : 20200416 0001809300-20-000001.hdr.sgml : 20200416 20200416123703 ACCESSION NUMBER: 0001809300-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200416 DATE AS OF CHANGE: 20200416 EFFECTIVENESS DATE: 20200416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alcinous Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001809300 IRS NUMBER: 850531640 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365160 FILM NUMBER: 20795699 BUSINESS ADDRESS: STREET 1: 14 BICKNELL AVENUE CITY: RUMFORD STATE: RI ZIP: 02916 BUSINESS PHONE: 4015293190 MAIL ADDRESS: STREET 1: 14 BICKNELL AVENUE CITY: RUMFORD STATE: RI ZIP: 02916 D 1 primary_doc.xml X0708 D LIVE 0001809300 Alcinous Pharmaceuticals, Inc. 14 BICKNELL AVENUE RUMFORD RI RHODE ISLAND 02916 4015293190 DELAWARE None None Corporation true 2020 Nicholas A. DaSilva 14 Bicknell Avenue Rumford RI RHODE ISLAND 02916 Executive Officer Director Kenneth N. Rose 14 Bicknell Avenue Rumford RI RHODE ISLAND 02916 Executive Officer Director Benjamin J. Barlock 14 Bicknell Avenue Rumford RI RHODE ISLAND 02916 Director Pharmaceuticals Decline to Disclose 06b false 2020-04-03 true true true true true false 1 600000 100000 500000 false 2 0 true 0 true 0 true false Alcinous Pharmaceuticals, Inc. Nicholas A. DaSilva Nicholas A. DaSilva CEO 2020-04-16